Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Managing Opioid Related Sleep Apnea With Acetazolamide
NCT06043830Phase 2Completed
- Sponsor
- University of California, San Diego
- Start
- Oct 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetazolamide in sleep disordered breathing (SDB), obstructive sleep apnea (OSA), central sleep apnea (CSA), sponsored by University of California, San Diego. Started Oct 2023; status: completed.
02
Drugs
acetazolamide
03
Conditions
sleep disordered breathing (SDB)obstructive sleep apnea (OSA)central sleep apnea (CSA)
Beyond the preview
Go deeper on NCT06043830.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06043830.